← Insider buys
TCRR

Tcr2 Therapeutics Inc.

10% owner Morana Jovan-Embiricos sold $740K of Tcr2 Therapeutics Inc.

Sold$740,387
$16.51Price
44,856Shares
−3%Stake

What TCRR did after the filing

Prices for TCRR after this filing aren't in yet.

Traded Wed, Dec 18. Filed Fri, Dec 20, 12:31 PM ET, during the session. Not investment advice.